Hexahydrocannabinol, usually shortened to HHC, is a hydrogenated form of THC that has spread through vape shops, gas stations, and online hemp retailers as a supposedly legal alternative to marijuana. Employers and testing programs keep asking the same question: does it trip a drug screen the same way THC does? The honest answer is that the published science is still thin, and what does exist is mixed. This post lays out what HHC actually is, what happens to it in the body, what the current research says about immunoassay and confirmation testing, and where the legal status stands.
What HHC Is and Why It Exists
HHC is made by adding hydrogen atoms to a THC molecule, a process called hydrogenation that is also used to turn vegetable oil into margarine. The result is a cannabinoid that is structurally close to delta 9 THC but not identical to it. Manufacturers typically synthesize HHC starting from cannabidiol (CBD) extracted from hemp, then market the finished product as hemp derived. That framing is the center of the legal argument these companies make, and it is also the reason HHC products have spread so quickly since hemp itself became federally legal.
Chemically, HHC exists as a mix of isomers (9R and 9S forms), and manufacturers do not always disclose the ratio or the purity of what ends up in a cartridge or gummy. Because HHC is produced through a chemical synthesis step rather than isolated directly from the plant in meaningful quantities, its regulatory status is contested, which we cover below.
What Happens to HHC in the Body
When HHC is metabolized, the body produces several metabolites, including hydroxylated forms and a carboxylated end product often written as HHC-COOH. That naming is deliberately similar to THC-COOH (11-nor-9-carboxy-THC), the primary urinary metabolite that standard drug test immunoassays are built to detect, because the two molecules are structurally close cousins.
A 2026 study published in the peer reviewed Journal of Xenobiotics and archived on the National Institutes of Health's PubMed Central platform developed a laboratory method to separate and measure THC-COOH and HHC metabolites in urine. The authors state plainly that "little information is available on the pharmacokinetics and metabolism of HHC in humans" and that further research is needed to map out its complete metabolic profile. That is not a marketing claim, it is a data gap acknowledged by the scientists doing the work, and it is the reason nobody should present HHC detection as settled science.
Does It Cross React on a Screening Immunoassay?
Screening tests, whether a urine cup, a dip card, or a lab based immunoassay, work by using antibodies that bind to a target molecule shape. They are not perfectly specific. If a metabolite is structurally similar enough to THC-COOH, it can sometimes trigger a positive result on a THC panel even though it is not THC. The same 2026 study notes that several countries have reported "false positive results associated with immunoassay techniques" tied to HHC, and that the World Health Organization has separately flagged false positives connected to HHC's presence as an ongoing testing challenge.
The practical answer, then, is that HHC use may or may not cause a THC panel to flag positive on a screening immunoassay. It depends on the specific antibody reagent used by that test's manufacturer, the concentration and isomer ratio of HHC metabolites present, and how recently and heavily the product was used. There is no single, confirmed cross reactivity percentage in the published literature, and any source that states one as a fixed number is going beyond what the current data supports.
What Happens at Confirmation
Confirmation testing is where the picture becomes clearer, though not simple. Reference laboratories confirm a presumptive positive using gas chromatography mass spectrometry (GC-MS) or liquid chromatography tandem mass spectrometry (LC-MS/MS), methods that identify a molecule by its exact mass and fragmentation pattern rather than by loose antibody binding. A standard THC confirmation panel is built and calibrated to identify THC-COOH specifically. Because HHC-COOH is a different molecule with a different mass, a standard THC-COOH confirmation assay is not calibrated to identify it and would generally not confirm it as THC.
That means a specimen that screens positive because of HHC metabolites can come back negative on a standard THC confirmation test, since the lab is confirming for a different compound than the one actually present. The authors of the 2026 metabolite study make this same point, stating that cannabis drug testing "cannot rely solely on immunoassay screening methods" given their limited specificity, and that confirmatory techniques like LC-MS/MS are necessary to tell THC and HHC metabolites apart. Some specialty forensic and toxicology labs have begun developing HHC specific confirmation methods, but that is not yet standard on a routine workplace THC panel, and the researchers themselves note they were unable to test authentic HHC positive human urine samples, leaving real world detection rates unresolved.
| Test stage | THC (delta 9) | HHC |
|---|---|---|
| Screening immunoassay (cup, dip card, lab screen) | Designed to detect THC-COOH directly | May or may not cross react, depending on the reagent and concentration; published data is limited |
| Standard GC-MS/LC-MS confirmation for THC-COOH | Confirms the specific target molecule | Generally does not confirm, since HHC-COOH is a different compound than THC-COOH |
| Specialty or research grade HHC assay | Not applicable | Exists in some forensic and toxicology settings, not standard on routine workplace panels |
How This Compares to Other Hemp Derived Cannabinoids
HHC is one of several hemp marketed cannabinoids that have raised similar questions, alongside delta 8 THC and THCA. Delta 8 is a THC isomer that occurs in trace amounts naturally and is usually concentrated through chemical conversion from CBD, and it does confirm on standard THC panels because its acid metabolite pathway overlaps closely with delta 9 THC. Our delta 8 THC drug testing guide walks through that comparison in more detail. THCA, the raw acidic precursor to delta 9 THC found in unheated cannabis plant material, converts to THC when heated and is addressed separately in our THCA drug test guide. HHC differs from both because it is a hydrogenated molecule rather than a naturally occurring isomer or acid precursor, which is exactly why its metabolic and testing profile is less studied and more uncertain.
Legal Status: Why HHC Exists in a Gray Area
The Agriculture Improvement Act of 2018, commonly called the Farm Bill, removed "hemp" from the federal Controlled Substances Act definition of marijuana, defining hemp as cannabis containing no more than 0.3 percent delta 9 THC on a dry weight basis. The full statutory text is available through the Government Publishing Office. The U.S. Department of Agriculture implemented the hemp production rules that followed from that law, which govern how hemp is grown and defined at the federal level, though they do not directly regulate finished consumer products like HHC vapes or edibles.
The Drug Enforcement Administration takes the position, laid out in its interim final rule implementing the 2018 Farm Bill, that synthetically derived tetrahydrocannabinols remain controlled substances regardless of the plant they originated from, since the statutory hemp exemption applies to the plant material and its natural derivatives within the THC threshold, not to lab modified cannabinoids. Under the federal Controlled Substances Act schedule for hallucinogenic substances, codified in the Code of Federal Regulations, "tetrahydrocannabinols" as a class are listed as Schedule I unless they fall within the specific hemp exemption. Whether HHC produced through chemical conversion of hemp derived CBD falls inside or outside that exemption has not been settled through federal rulemaking specific to HHC, and state legislatures have moved on their own timelines to restrict or ban HHC and similar semi synthetic cannabinoids. Because this varies by state and continues to change, employers and individuals should check current state law and consult legal counsel rather than assume a product is legal everywhere it is sold.
What This Means for Employer Drug Testing Programs
Employers running federally mandated testing programs, such as those under Department of Transportation rules, test specifically for THC-COOH using cutoff levels set out in the federal mandatory guidelines administered through the Department of Health and Human Services and the Substance Abuse and Mental Health Services Administration. Those programs are not built around HHC and generally will not specifically pursue an HHC positive as a distinct category. For general workplace programs using standard urine cups, dip cards, or oral fluid tests, the same limitation applies: a positive screen tied to HHC use may or may not confirm as THC, and a negative confirmation does not necessarily mean no cannabinoid use occurred, it may mean the specific molecule tested for was not present in a detectable amount.
Given that ambiguity, employer drug and alcohol policies benefit from language that addresses "any cannabinoid product, including hemp derived and semi synthetic cannabinoids such as HHC, delta 8, and delta 10," rather than referring only to "marijuana" or "THC," since a policy written narrowly can leave a documented gap. Any adverse employment decision tied to a drug test result should still go through the employer's standard verification process, including review by a Medical Review Officer where applicable, since a nonnegative result on its own is not a final determination.
Frequently Asked Questions
Does HHC show up as a positive THC result on a drug test?
It might, but the outcome is not consistent or certain. Published research indicates HHC metabolites can cross react with some THC screening immunoassays, causing a presumptive positive, but this depends on the test reagent and how much HHC metabolite is present. It is not something that can be predicted with certainty for a given product or person.
Will HHC confirm as THC in a lab confirmation test?
Generally, no. Standard confirmation methods are calibrated to identify THC-COOH specifically. Since HHC breaks down into a different metabolite, HHC-COOH, a standard THC confirmation assay is not built to identify it as THC, though specialty labs are developing HHC specific methods.
Is HHC legal?
The legal status is unsettled and varies by state. The 2018 Farm Bill excludes hemp within a 0.3 percent delta 9 THC threshold from the federal controlled substances definition of marijuana, but the DEA has taken the position that synthetically derived THC compounds remain controlled regardless of source. Several states have separately banned or restricted HHC. Check current state law and consult an attorney for a specific situation.
Can an employer test specifically for HHC?
Routine workplace panels are not generally built to target HHC specifically. Some specialty toxicology and forensic laboratories have developed research methods to identify HHC metabolites, but this is not standard on a typical urine cup, dip card, or oral fluid workplace panel.
Is HHC the same as delta 8 or delta 10 THC?
No. HHC is a hydrogenated THC molecule, while delta 8 and delta 10 are THC isomers that differ in the position of a chemical double bond. All three are marketed as hemp derived alternatives to delta 9 THC, but they are chemically distinct and may behave differently on a drug test.
Should a workplace drug policy mention HHC by name?
Many employers find it useful to write policy language that covers hemp derived and semi synthetic cannabinoids broadly, rather than only the word marijuana or THC, since new cannabinoid products continue to enter the market. A policy reviewed by legal counsel can address this gap directly.
Testing Products for Cannabinoid Screening Programs
Employers building or updating a cannabinoid testing program can review our drug test cups for standard THC panel screening options used in workplace programs nationwide.
This article is for general informational purposes only and is not legal or medical advice. Drug testing laws, cannabinoid regulations, and workplace policy requirements vary by state and change over time; consult qualified legal counsel and a Medical Review Officer for guidance specific to your situation.
Sources: Agriculture Improvement Act of 2018 (Public Law 115-334), U.S. Government Publishing Office; USDA Agricultural Marketing Service, hemp rules and regulations; DEA interim final rule, Implementation of the Agriculture Improvement Act of 2018, Federal Register; 21 CFR Part 1308, Schedules of Controlled Substances, Electronic Code of Federal Regulations; Cabarcos-Fernandez et al., determination of THC-COOH and hexahydrocannabinol metabolites in urine, Journal of Xenobiotics, National Institutes of Health PubMed Central; SAMHSA, workplace drug testing programs.
